Gates Medical Research Institute
Clinical trials sponsored by Gates Medical Research Institute, explained in plain language.
-
New TB drug combo enters phase 2 trial – hope for shorter treatment?
Disease control Recruiting nowThis study tests whether adding a new drug called TBD09 to standard TB medicines is safe and works better at killing TB bacteria. About 150 adults with drug-sensitive pulmonary TB will take part. The goal is to see if the combination can clear the infection faster and with fewer …
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated May 17, 2026 04:41 UTC
-
Could a vitamin boost TB treatment? new trial underway
Disease control Recruiting nowThis study tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible tuberculosis (TB) in adults. About 165 participants with newly diagnosed, drug-sensitive TB will receive the combination or stand…
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC